Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Among the winners is Jeffrey Gundlach’s $31 billion DoubleLine Total Return Bond Fund at DoubleLine Capital LP. The fund, which invests in high-grade U.S. mortgage-backed securities and Treasury bonds, handed investors a return of 2.21% in January, beating 99% of its peers, according to fund tracker Morningstar Inc. The fund returned 0.02% in 2013….
Mr. Gundlach declined to comment Wednesday. In a webcast to investors in January, Mr. Gundlach said he expects the 10-year Treasury yield could drop back down toward 2.50%.
The 10-year Treasury yield rose Wednesday to 2.668% from 2.622% late Tuesday after a report showing faster expansion in the U.S. service sector dented buying in the safe-haven market. However, the yield is still lower than the 3.03% where it was at the end of last year.